Unique, expert portfolio

Size: px
Start display at page:

Download "Unique, expert portfolio"

Transcription

1 EPIGENETICS Enzymes Kits Cell Lines Screening Services INNOVATIVE PRODUCTS TO FUEL YOUR EXPERIMENTS Unique, expert portfolio

2 HISTONE METHYLTRANSFERASES HISTONE DEMETHYLASES ACETYLTRANSFERASES BROMODOMAINS DEACETYLASES RECOMBINANT, ASSAY READY PROTEINS > 200 INCLUDING COMPLEXES INHIBITOR SCREENING ASSAYS > 200 AVAILABLE INHIBITORS & ANTIBODIES METHYLATION, CHROMATIN, CANCER, TRANSCRIPTION SUBSTRATES HISTONES, OCTAMERS, NUCLEOSOMES, BIOTINYLATED VERSIONS CUSTOM & BULK PRODUCTION CLONING, SCALE-UP, PURIFICATION, EXPRESSION SCREENING SERVICES MULTIPLE DETECTION METHODS TABLE OF CONTENTS BPS ADVANTAGES 3 ACETLYTRANSFERASES 4 BROMODOMAINS 5 DEACETYLASES/SIRTUINS 8 DEMETHYLASES 11 METHYLTRANSFERASES 13

3 BPS ADVANTAGES MADE IN HOUSE GET ANSWERS STRAIGHT FROM THE SOURCE OPTIMAL TECH AND CUSTOMER SUPPORT > 12 YEARS EXPERIENCE CITED IN HUNDREDS OF PUBLICATIONS MATURE PROTEIN PORTFOLIO FULL HDAC AND SIRTUIN SUITE MOST EXTENSIVE DNMT OFFERING ON MARKET HUMAN, MURINE, AND MONKEY VERSIONS OF RECOMBINANT PROTEINS MULTIPLE TAGGED VERSIONS INCLUDING GST, FLAG, HIS, STREPTAVIDIN (AVI-TAG ) PROTEIN COMPLEXES PROTEIN MUTANTS FULL LENGTH AND CATALYTIC DOMAINS HIP PROTEINS = HIGH PURITY & LOW AGGREGATION (VIA FPLC) MULTIPLE READ OUT METHODS FOR ASSAYS ALPHA SCREEN CHEMILUMINESCENCE FLUORESCENCE INTENSITY FLUORESCENCE POLARIZATION (FP) TIME-RESOLVED FLUOROMETRIC TR-FRET/FRET (HTRF) EXPRESSION & SCREENING SERVICES

4 ACETYLTRANSFERASE(S) GCN5 Chemiluminescent Assay Kit 50079L 96 reactions GCN5 Fluorogenic Assay Kit reactions P300 (KAT3B) Fluorogenic Assay Kit reactions P300 Homogeneous Assay Kit reactions 10x HAT Assay Buffer ml AICAR mg ATAT1, GST-tag µg C mg C mg GCN5 (KAT2A), FLAG-tag µg HAT Stop Solution ml KAT5 (TIP60), GST-Tag µg p300 (KAT3B), His-GST-tags µg P300 Chemiluminescent Assay Kit 50077L 96 reactions 4

5 BROMODOMAIN(S) ATAD2A Inhibitor Screening Assay Kit reactions ATAD2A TR-FRET Assay Kit reactions ATAD2B Inhibitor Screening Assay Kit reactions ATAD2B TR-FRET Assay Kit reactions BAZ2B Inhibitor Screening Assay Kit reactions BPTF/FALZ TR-FRET Assay Kit reactions BRD1 Inhibitor Screening Assay Kit reactions BRD1 TR-FRET Assay Kit reactions BRD2 (BD1+BD2) TR-FRET Assay Kit reactions BRD2 (BD2) Inhibitor Screening Assay Kit reactions BRD3 (BD1) Inhibitor Screening Assay Kit reactions BRD3 (BD1+BD2) TR-FRET Assay Kit reactions BRD3 (BD2) Inhibitor Screening Assay Kit reactions BRD4 (BD1) Inhibitor Screening Assay Kit reactions BRD4 (BD1) TR-FRET Assay Kit reactions BRD4 (BD1+BD2) TR-FRET Assay Kit reactions BRD4 (BD2) Inhibitor Screening Assay Kit reactions BRD4 (BD2) TR-FRET Assay Kit reactions BRD9 (BD1) Inhibitor Screening Assay Kit reactions BRD9 TR-FRET Assay Kit reactions BRDT (BD1+BD2) TR-FRET Assay Kit reactions BRPF3 Inhibitor Screening Assay Kit reactions BRPF3 TR-FRET Assay Kit reactions CECR2 Inhibitor Screening Assay Kit reactions CECR2 TR-FRET Assay Kit reactions CREBBP Inhibitor Screening Assay Kit reactions SMARCA2 Inhibitor Screening Assay Kit reactions SMARCA4/BRG1 Inhibitor Screening Assay Kit reactions TAF1 (BD1+BD2) TR-FRET Assay Kit reactions TAF1 (BD1/BD2) Inhibitor Screening Assay Kit reactions TAF1 (BD2) Inhibitor Screening Assay Kit reactions TAF1 (BD2) TR-FRET Assay Kit reactions TAF1L (BD1+BD2) TR-FRET Assay Kit reactions TAF1L (BD1/BD2) Inhibitor Screening Assay Kit reactions TAF1L (BD2) Inhibitor Screening Assay Kit reactions 5

6 BROMODOMAIN(S) (CONT'D) TRIM24 Inhibitor Screening Assay Kit reactions TRIM24 TR-FRET Assay Kit reactions WDR9/BRWD1 TR-FRET Assay Kit reactions (+)-JQ mg (+)-JQ mg (+)-JQ mg (-)-JQ mg (-)-JQ mg 3x BRD Homogeneous Assay Buffer ml 3x BRD Homogeneous Assay Buffer ml 3x BRD Homogeneous Assay Buffer ml 3x BRD Homogeneous Detection Buffer ml 3x BRD Homogeneous Detection Buffer ml 3x BRD TR-FRET Assay Buffer ml 3x BRD TR-FRET Assay Buffer ml 3x Homogeneous BRD Detection Buffer ml ASH1L, His-tag µg ATAD2A, GST-tag µg ATAD2A, His-tag µg ATAD2B (KIAA1240), GST-tag µg ATAD2B (KIAA1240), His-tag µg BACE1 FRET Assay Kit reactions BAZ1A, GST-tag µg BAZ1B, GST-tag µg BAZ1B, His-tag µg BAZ2B, His-tag µg BET Bromodomain Ligand µm BRD1, GST-tag µg BRD1, His-tag µg BRD2 (BD1), GST-tag µg BRD2 (BD1), His-tag µg BRD2 (BD1+BD2), GST-tag µg BRD2 (BD1+BD2), His-tag µg BRD2 (BD2), GST-tag µg BRD2 (BD2), His-tag µg BRD3 (BD1), GST-tag µg BRD3 (BD1), His-tag µg BRD3 (BD1+BD2), GST-tag µg BRD3 (BD1+BD2), His-tag µg BRD3 (BD2), GST-tag µg BRD3 (BD2), His-tag µg BRD4 (BD1), GST-tag µg BRD4 (BD1), His-tag µg BRD4 (BD1+BD2) µg BRD4 (BD1+BD2), GST-tag µg BRD4 (BD1+BD2), His-tag µg BRD4 (BD2), GST-tag µg BRD4 (BD2), His-tag µg BRD9, GST-tag µg BRD9, His-tag µg BRDT (BD1), GST-tag µg BRDT (BD1), His-tag µg BRDT (BD1+BD2), GST-tag µg BRDT (BD2), GST-tag µg BRDT (BD2), His-tag µg Bromodomain Ligand µm Bromodomain Ligand µm Bromodomain Ligand µm Bromodomain Non-Acetylated Ligand µm Bromodomain Non-Acetylated Ligand µm Bromodomain Non-Acetylated Ligand µm Bromodomain Non-Acetylated Ligand µm Bromosporine mg BRPF1, His-tag µg BRPF3, GST-tag µg CECR2, GST-tag µg CECR2, His-tag µg CHS mg CREBBP (KAT3A), GST-tag µg CREBBP (KAT3A), His-tag µg CREBBP TR-FRET Assay Kit Reactions FALZ (BPTF), GST-tag µg FALZ (BPTF), His-tag µg GCN5 ( ), His-tag µg I-BET mg I-BET mg I-BET151 (GSK A) mg I-BET151 (GSK A) mg I-BET151 (GSK A) mg I-CBP112 (Hydrochloride) mg OTX mg OTX mg OTX mg P300 ( ), His-tag µg 6

7 BROMODOMAIN(S) (CONT'D) PB1 (BD4), His-tag µg PB1 (BD6), His-tag µg PCAF (KAT2B), His-tag µg PFI mg PHIP (BD1), GST-tag µg PHIP (BD1), His-tag µg RediSolution (+)-JQ mg RVX mg SGC-CBP mg SGC-CBP mg SMARCA2 TR-FRET Assay Kit reactions SMARCA2, GST-tag µg SMARCA2, His-tag µg SMARCA2, His-Tag, Biotin-Labeled μg SMARCA4 (BRG1), GST-tag µg SMARCA4 (BRG1), His-tag µg SMARCA4/BRG1 TR-FRET Assay Kit reactions TAF1 (BD1), His-tag µg TAF1 (BD1+BD2), GST-tag µg TAF1 (BD2), GST-tag µg TAF1 (BD2), His-tag µg TAF1L (BD1), GST-tag µg TAF1L (BD1), His-tag µg TAF1L (BD1+BD2), GST-tag µg TAF1L (BD2), GST-tag µg TAF1L (BD2), His-tag µg TRIM24 (TIF1), GST-tag µg TRIM24 (TIF1), His-tag µg TRIM28, GST-tag µg TRIM28, His-tag µg WDR9/BRWD1 (BD2), GST-tag µg WDR9/BRWD1 (BD2), His-tag µg ZMYND11, GST-tag µg ZMYND8, GST-tag µg 7

8 DEACETYLASE(S)/SIRTUINS HDAC class 2a Fluorogenic Assay Kit reactions HDAC Fluorogenic Assay Kit reactions HDAC Fluorogenic Assay Kit (Green) reactions HDAC1 Fluorogenic Assay Kit reactions HDAC1 Kinetic Assay Kit reactions HDAC2 Fluorogenic Assay Kit reactions HDAC2 Kinetic Assay Kit reactions HDAC3 Fluorogenic Assay Kit reactions HDAC3 Kinetic Assay Kit reactions HDAC4 Fluorogenic Assay Kit reactions HDAC5 Fluorogenic Assay Kit reactions HDAC7 Fluorogenic Assay Kit reactions HDAC8 Fluorogenic Assay Kit reactions HDAC9 Fluorogenic Assay Kit reactions SIRT1 (Sirtuin1) Fluorogenic Assay Kit reactions SIRT2 (Sirtuin2) Fluorogenic Assay Kit reactions SIRT3 (Sirtuin3) Fluorogenic Assay Kit reactions SIRT5 (Sirtuin5) Fluorogenic Assay Kit reactions (S)-HDAC mg 4-iodo-SAHA mg AGK mg Apicidin mg AR-42 (OSU-HDAC42) mg AR-42 (OSU-HDAC42) mg AR-42 (OSU-HDAC42) mg Belinostat (PXD101) mg Belinostat (PXD101) mg Belinostat (PXD101) mg CBHA mg Chidamide mg CI mg CUDC mg 8

9 DEACETYLASE(S)/SIRTUINS (CONT'D) Droxinostat mg Droxinostat mg EX mg Fluorogenic HDAC class 2a substrate nmole Fluorogenic HDAC class 2a substrate 2 (green) nmole Fluorogenic HDAC substrate nmole Fluorogenic HDAC Substrate 2 (Green fluorescence) nmole Fluorogenic HDAC substrate nmole Fluorogenic SIRT substrate nmole Fluorogenic Sirtuin 5 Substrate nmole Fluorogenic Sirtuin 6 Substrate µl HC Toxin µg HDAC Assay Buffer ml HDAC developer (2X) ml HDAC1, FLAG-tag, His-tag µg HDAC1, His-Tag, FLAG-Tag (Mouse) µg HDAC10, GST-tag, His-tag µg HDAC10, N-FLAG-tag µg HDAC µg HDAC11 Fluorogenic Assay Kit reactions HDAC11, GST-tag µg HDAC2, FLAG-tag µg HDAC2, His-tag µg HDAC3/NcoR2 Complex, His-tag µg HDAC4, GST-tag, His-tag µg HDAC5 (full length), GST-tag µg HDAC5, Catalytic Domain, His-tag µg HDAC6 (H216A), GST-tag µg HDAC6 (H611A), GST-tag µg HDAC6 Fluorogenic Assay Kit reactions HDAC6, FLAG-tag µg HDAC6, GST-tag µg HDAC6, GST-Tag (Mouse) µg HDAC7, GST-tag µg HDAC8, His-tag µg HDAC9, His-tag µg HNHA mg ITF mg JNJ mg JNJ mg JNJ mg Kaempferol mg Kinetic HDAC Assay Developer ml LAQ824 (NVP-LAQ824,Dacinostat) mg LAQ824 (NVP-LAQ824,Dacinostat) mg M mg MC mg MC mg Mocetinostat mg MS-275 (Entinostat) mg NcoR2 (SMRT), GST-tag µg Oxamflatin mg Oxamflatin mg Panobinostat mg Parthenolide mg Parthenolide mg PCI mg PCI (CRA ) mg PCI (CRA ) mg PCI (CRA ) mg pf-hdac1, Malaria, His-tag, FLAG-tag µg Pracinostat (SB939) mg Pracinostat (SB939) mg Pracinostat (SB939) mg Pyroxamide mg Resminostat (RAS2410) mg Resminostat (RAS2410) mg Resveratrol mg Resveratrol mg Resveratrol mg RGFP mg RGFP mg RGFP mg Rocilinostat (ACY-1215) mg Rocilinostat (ACY-1215) mg Rocilinostat (ACY-1215) mg Romidepsin (FK228, depsipeptide) mg Romidepsin (FK228, depsipeptide) mg SAHA (Vorinostat) mg Salermide mg SB mg Scriptaid mg SIRT1/2 Inhibitor IV mg Sirtinol mg 9

10 DEACETYLASE(S)/SIRTUINS (CONT'D) Droxinostat mg Droxinostat mg EX mg Fluorogenic HDAC class 2a substrate nmole Fluorogenic HDAC class 2a substrate 2 (green) nmole Fluorogenic HDAC substrate nmole Fluorogenic HDAC Substrate 2 (Green fluorescence) nmole Fluorogenic HDAC substrate nmole Fluorogenic SIRT substrate nmole Fluorogenic Sirtuin 5 Substrate nmole Fluorogenic Sirtuin 6 Substrate µl HC Toxin µg HDAC Assay Buffer ml HDAC developer (2X) ml HDAC1, FLAG-tag, His-tag µg HDAC1, His-Tag, FLAG-Tag (Mouse) µg HDAC10, GST-tag, His-tag µg HDAC10, N-FLAG-tag µg HDAC µg HDAC11 Fluorogenic Assay Kit reactions HDAC11, GST-tag µg HDAC2, FLAG-tag µg HDAC2, His-tag µg HDAC3/NcoR2 Complex, His-tag µg HDAC4, GST-tag, His-tag µg HDAC5 (full length), GST-tag µg HDAC5, Catalytic Domain, His-tag µg HDAC6 (H216A), GST-tag µg HDAC6 (H611A), GST-tag µg HDAC6 Fluorogenic Assay Kit reactions HDAC6, FLAG-tag µg HDAC6, GST-tag µg HDAC6, GST-Tag (Mouse) µg HDAC7, GST-tag µg HDAC8, His-tag µg HDAC9, His-tag µg HNHA mg ITF mg JNJ mg JNJ mg JNJ mg Kaempferol mg 10

11 DEMETHYLASE(S) FBXL10 (KDM2B) Homogeneous Assay Kit reactions FBXL11 (KDM2A) Homogeneous Assay Kit reactions JARID1A (KDM5A) Homogeneous Assay Kit reactions JARID1B (KDM5B) Homogeneous Assay Kit reactions JARID1C (KDM5C) Homogeneous Assay Kit reactions JHDM1D (KDM7A) Homogeneous Assay Kit reactions JMJD1A (KDM3A) Homogeneous Assay Kit reactions LSD1 (KDM1A) Chemiluminescent Assay Kit reactions LSD1 (KDM1A) Fluorescent Assay Kit reactions LSD1 (KDM1A) Fluorescent Assay Kit reactions LSD1 (KDM1A) Homogeneous Assay Kit reactions 2x LSD1 Buffer ml 3x LSD1 Buffer ml 4x DMT Detection Buffer ml 4x HDM Assay Buffer ml 4x HDM Assay Buffer ml 4x HDM Assay Buffer ml 4x HDM Assay Buffer ml 4x HDM Incomplete Assay Buffer ml Anti-Dimethyl Histone H3 (Lys27) Monoclonal, Primary Antibody F 25 µl Anti-JMJD1A, Primary Antibody Q 25 µl Anti-JMJD2, Primary Antibody E 40 μl Blocking Buffer ml FBXL10 (KDM2B) Chemiluminescent Assay Kit reactions FBXL10 (KDM2B, JHDM1B), FLAG-tag µg FBXL11 (KDM2A, JHDM1A), FLAG-Avi-tags µg FTO Chemiluminescent Assay Kit reactions FTO, His-Tag µg GSK J4 HCl mg GSK J4 HCl mg H3K4me2 Substrate μl Histone H3 K27cMe1, Full Length, His-tag µg Histone H3 K27cMe2, Full Length, His-tag µg Histone H3 K27cMe3, Full Length, His-tag µg Histone H3 peptide (1-21), Dimethyl K9, Biotin-labeled µl 11

12 DEMETHYLASE(S) (CONT'D) Histone H3 peptide (1-21), Monomethyl K9, Biotin-labeled µl Histone H3 peptide (1-21), Trimethyl K9, Biotin-labeled µl Histone H3-H4 Tetramer H3K27cMe2, His-tag µg Histone H3-H4 Tetramer H3k27cMe3, His-tag µg Histone Octamer H3K27cMe2, His-tag µg Histone Octamer H3K27cMe3, His-tag µg JARID1A (KDM5A) Chemiluminescent Assay Kit reactions JARID1A (KDM5A), FLAG-tag µg JARID1A (KDM5A), His-Avi-tags, FLAG-tag µg JARID1B (KDM5B) Chemiluminescent Assay Kit reactions JARID1B (KDM5B) TR-FRET Assay Kit reactions JARID1B (KDM5B), Full Length, FLAG-tag µg JARID1B (KDM5B, PLU-1), His-FLAG-tags µg JARID1C(KDM5C), FLAG-tag µg JHDM1D (KDM7A) Chemiluminescent Assay Kit reactions JHDM1D (KDM7A), FLAG-tag µg JMJD1A (KDM3A), FLAG-tag µg JMJD1B (KDM3B), FLAG-tag µg OG-L mg OG-L mg PHF8 (KDM7B) Homogeneous Assay Kit reactions PHF8 (KDM7B), (2-525), FLAG-tag μg PHF8 (KDM7B), Full-length, FLAG-tag μg Posaconazole mg Posaconazole mg Secondary Anti-HRP-labeled Antibody H 10 µl TET1 Chemiluminescent Assay Kit reactions TET1, FLAG-tag µg TET2 Chemiluminescent Assay Kit reactions TET2, FLAG-His-tag ug TET3, FLAG-Tag, His-Tag µg Tranylcypromine (2-PCPA) mg UTX (KDM6A), C-term FLAG-tag µg UTX (KDM6A), N-terminal FLAG-tag μg UTX Chemiluminescent Assay Kit reactions UTX(KDM6A) Homogeneous Assay Kit reactions JMJD2A (KDM4A) Homogeneous Assay Kit reactions JMJD2A(KDM4A) (1-350), His-tag µg JMJD2B (KDM4B) Homogeneous Assay Kit reactions JMJD2B (KDM4B), GST-tag µg JMJD2B(KDM4B), FLAG-tag µg JMJD2C (KDM4C) Chemiluminescent Assay Kit reactions JMJD2C (KDM4C) Homogeneous Assay Kit reactions JMJD2C, GST-Tag µg JMJD2D (KDM4D) Chemiluminescent Assay Kit reactions JMJD2D (KDM4D), GST-tag µg JMJD2E (KDM4DL) Homogeneous Assay Kit reactions JMJD2E (KDM4DL), GST-tag µg JMJD3 (KDM6B) Chemiluminescent Assay Kit reactions JMJD3 (KDM6B) Homogeneous Assay Kit reactions JMJD3 (KDM6B), FLAG-tag µg JMJD6, GST-tag µg LSD1 (KDM1A), Variant µg LSD1 (KDM1A), Variant 2, GST-tag µg LSD1 Substrate µl LSD1 Variant 1, GST-tag µg LSD2 (KDM1B), GST-Tev-Tag µg LSD2(KDM1B) Homogeneous Assay Kit (Dimethyl) reactions LSD2(KDM1B) Homogeneous Assay Kit (Monomethyl) reactions Mouse JARID1B (KDM5B, PLU-1), FLAG-tag µg 12

13 METHYLTRANSFERASE(S) DNMT Universal Chemiluminescent Assay Kit reactions DNMT1 Chemiluminescent Assay Kit 52050L 96 reactions DNMT3A Chemiluminescent Assay Kit reactions DNMT3B Chemiluminescent Assay Kit reactions DOT1L (KMT4) Chemiluminescent Assay Kit reactions EHMT1/GLP Chemiluminescent Assay Kit reactions EZH1 Chemiluminescent Assay Kit reactions EZH1 Chemiluminescent Assay Kit reactions EZH2 (A677G) Chemiluminescent Assay Kit reactions EZH2 (Y641F) Chemiluminescent Assay Kit reactions EZH2 (Y641N) Chemiluminescent Assay Kit reactions EZH2 (Y641N) TR-FRET Assay Kit reactions EZH2 Chemiluminescent Assay Kit 52009L 96 reactions EZH2 Homogeneous Assay Kit reactions G9a Chemiluminescent Assay Kit 52001L 96 reactions G9a Homogeneous Assay Kit reactions Histone H3(K9) Universal Methyltransferase New Assay Kit reactions Histone H4(R3) Methyltransferase Assay Kit reactions MLL1 Complex Chemiluminescent Assay Kit reactions NSD1 Chemiluminescent Assay Kit reactions NSD2 Chemiluminescent Assay Kit reactions PRMT1 Chemiluminescent Assay Kit 52004L 96 reactions PRMT1 Homogeneous Assay Kit reactions PRMT3 Chemiluminescent Assay Kit 52005L 96 reactions PRMT3 Homogeneous Assay Kit reactions PRMT4 Chemiluminescent Assay Kit 52041L 96 reactions PRMT5 Chemiluminescent Assay Kit 52002L 96 reactions PRMT5 Homogeneous Assay Kit reactions PRMT8 Homogeneous Assay Kit reactions SETD2 Chemiluminescent Assay Kit reactions SetDB1 Chemiluminescent Assay Kit reactions SUV39H1 Chemiluminescent Assay Kit 52006L 96 reactions SUV39H2 Chemiluminescent Assay Kit 52008L 96 reactions SUV4-20H1 Chemiluminescent Assay Kit reactions 3-Deazaneplanocin (DZNep) mg 13

14 METHYLTRANSFERASE(S) (CONT'D) 3-Deazaneplanocin (DZNep) mg 3-Deazaneplanocin A (DZNep) hydrochloride mg 3-Deazaneplanocin A (DZNep) hydrochloride mg 400 µm S-Adenosylmethionine µl 4x DNMT Assay Buffer ml 4x DNMT Assay Buffer ml 4x HMT Assay Buffer ml 4x HMT Assay Buffer A 30 ml 4x HMT Assay Buffer ml 4x HMT Assay Buffer 2A A 30 ml 4x HMT Assay Buffer ml 4x HMT Assay Buffer ml 4x HMT Assay Buffer ml 4x HMT Assay Buffer ml 4x HMT Assay Buffer ml AEBP2, His-tag µg AMI-1 (sodium salt) mg Anti- Adenosyl Homocysteine Antibody ml Anti-Dimethyl Histone H3 (Lys27) Monoclonal, Primary 52140F 25 µl Antibody 6 Anti-JMJD1A, Primary Antibody Q 25 µl Anti-JMJD2, Primary Antibody E 40 μl Anti-Trimethyl Histone H3 (Lys27) Monoclonal 52140C µl Anti-Trimethyl Histone H3 (Lys27) Monoclonal 52140C µl Azacytidine (Vidaza) mg BIX01294 (hydrochloride hydrate) mg Blocking Buffer ml Chaetocin mg Core Histone Octamers mg CoREST, His-tag µg CTPB mg DNMT1, GST-tag µg DNMT1, His-FLAG-tags µg DNMT2, GST-tag µg DNMT3a, GST-tag µg DNMT3A/DNMT3L Complex, His-tag, GST-tag µg DNMT3B/DNMT3L Complex, GST-tag, His-tag µg DNMT3B/DNMT3L Complex, His-tag, GST-tag µg DOT1L (KMT4), GST-tag µg EED, FLAG-tag µg EHMT1 (GLP), GST-tag µg Ellagic acid mg Entacapone mg Entacapone mg EPZ mg EPZ mg EPZ mg EPZ mg EPZ mg EPZ mg EPZ mg EPZ mg EPZ mg EPZ mg EZH1/EED/SUZ12, His-tag µg EZH1/EED/SUZ12/RbAp48/AEBP2, His-tag µg EZH2 (A677G) Chemiluminescent Assay Kit reactions EZH2 (A677G)/EED/SUZ12/RbAp48/AEBP2, His-tag µg EZH2 (A677T)/EED/SUZ12/RbAp48/AEBP2, His-tag µg EZH2 (A687V)/EED/SUZ12/RbAp48/AEBP2, His-tag µg EZH2 (A738T) /EED/SUZ12/RbAp48/AEBP2, FLAG-Tag, µg His-Tag EZH2 (A738T) Chemiluminescent Assay Kit reactions EZH2 (A738T) Chemiluminescent Assay Kit reactions EZH2 (del153y)/eed/suz12/rbap48/aebp2, FLAG, His-tag µg EZH2 (E740K)/EED/SUZH12/RbAp48/AEBP2, FLAG-tag, His-tag µg EZH2 (F667I)/EED/SUZH12/RbAp48/AEBP2, FLAG-tag, His-tag µg EZH2 (H689Y)/EED/SUZ12/RbAp48/AEBP2, FLAG-tag, His-tag µg EZH2 (non-complexed), His-GST-tags µg EZH2 (P132S)/EED/SUZ12/RbAp48/AEBP2, FLAG-tag, His-tag µg EZH2 (R679C)/EED/SUZH12/RbAp48/AEBP2, FLAG-tag, µg His-tag EZH2 (Y641C) /EED/SUZ12/RbAp48/AEBP2, His-tag µg EZH2 (Y641F) /EED/SUZ12/RbAp48/AEBP2, His-tag µg EZH2 (Y641F) Chemiluminescent Assay Kit reactions EZH2 (Y641H) /EED/SUZ12/RbAp48/AEBP2, His-tag µg EZH2 (Y641N) /EED/SUZ12/RbAp48/AEBP2, His-tag, FLAG-tag µg EZH2 (Y641N) Chemiluminescent Assay Kit reactions EZH2 (Y641S) /EED/SUZ12/RbAp48/AEBP2, His-tag µg EZH2 / EED / SUZ12, His-tag, FLAG-tag µg EZH2 Chemiluminescent Assay Kit reactions EZH2(Y641F) TR-FRET Assay Kit reactions EZH2-EED Binding Assay Kit reactions EZH2/EED, His-tag, FLAG-tag µg EZH2/EED/SUZ12/RbAp48, His-tag, FLAG-tag µg EZH2/EED/SUZ12/RbAp48/AEBP2, FLAG-tag, His-tag µg EZH2/SUZ12/RbAp48, His-GST-tags, His-tag µg 14

15 METHYLTRANSFERASE(S) (CONT'D) G9a (EHMT2), GST-tag (E. coli-derived) µg G9a (EHMT2), GST-tag (Sf9-derived) µg Histone H1, Full Length, His-tag µg Histone H1, Full Length, His-tag mg Histone H2a, Full Length, Biotin-labeled, His-tag µg Histone H2a, Full Length, Biotin-labeled, His-tag mg Histone H2a, Full Length, His-tag mg Histone H2a, Full Length, His-tag µg Histone H2b, Full Length, His-tag µg Histone H2b, Full Length, His-tag mg Histone H mg Histone H μg Histone H3 (2-58), GST-tag µg Histone H3 (K27M), His-tag µg Histone H3 Dimethyl-K27 ELISA Detection Kit reactions Histone H3 K27C, Full Length, His-tag µg Histone H3 K27cMe1, Full Length, His-tag µg Histone H3 K27cMe2, Full Length, His-tag µg Histone H3 peptide (1-21) nmole Histone H3 peptide (1-21), Biotin-labeled nmole Histone H3 peptide (21-44) nmole Histone H3 peptide (21-44), Biotin-labeled nmole Histone H3 Peptide (21-44), Monomethyl K27, Biotin-labeled nmole Histone H3, Full Length, Biotin-labeled, His-tag µg Histone H3, Full Length, Biotin-labeled, His-tag mg Histone H3, Full Length, His-tag µg Histone H3, Full Length, His-tag mg Histone H3-H4 Tetramer H3K27C Unmodified, His-tag µg Histone H3-H4 Tetramer H3K27cMe2, His-tag µg Histone H3/H4 Tetramer (full length), His-tag µg Histone H3/H4 Tetramer (full length), His-tag µg Histone H4 (2-58), GST-tag µg Histone H4 peptide (1-21) nmole Histone H4 peptide (1-21), Biotin-labeled nmole Histone H4 peptide (1-21), Dimethyl R3, Biotin-labeled µl Histone H4, Full Length, His-tag mg Histone H4, Full Length, His-tag µg Histone Octamer (Full length) μg Histone Octamer (full length), His-tag μg Histone Octamer H3K27C Unmodified, His-tag µg Histone Octamer H3K27cMe2, His-tag µg Histone Octamer, Biotin-labeled, His-tag µg Histone-H2A-( )-Ac-OH mg Histone-H2A-( )-Ac-OH mg MECP2, GST-tag µg Metnase (SETMAR), FLAG-tag µg METTL3/METTL14 Complex, GST-Tag µg MLL1/WDR5/Ash2L/RbBP5 (MLL1/WAR Complex), His-tag µg MLL1/WDR5/Ash2L/RbBP5/DPY30 (MLL1/WARD Complex), µg FLAG, His-tag Mouse DNMT3B, His-tag, FLAG-tag µg Native nucleosome (HEK293-derived) mg Native Nucleosome (HeLa-derived) mg NSD1, GST-tag μg NSD2 (catalytic domain), GST-tag µg NSD2 Chemiluminescent Assay Kit reactions NSD3 ( ) (WHSC1L1), GST-tag µg NSD3 Chemiluminescent Assay Kit reactions NSD3 Chemiluminescent Assay Kit reactions PRDM12, GST-tag µg PRDM14, GST-tag µg PRMT1, GST-tag (E. coli-derived) µg PRMT1, GST-tag (Sf9-derived) µg PRMT3, GST-tag µg PRMT4 (CARM1), FLAG-tag (HEK293-derived) µg PRMT4 Homogeneous Assay Kit reactions PRMT4 peptide substrate, Biotin-labeled nmole PRMT5 Chemiluminescent Assay Kit reactions PRMT5 TR-FRET Assay Kit reactions PRMT5/MEP50, Biotin-Labeled µg PRMT5/MEP50, FLAG-tag, His-tag (HEK293-derived) µg PRMT5/MEP50, FLAG-tag, His-tag (Sf9-derived) µg PRMT6 (HRMT1L6) Chemiluminescent Assay Kit reactions PRMT6 (HRMT1L6) Homogeneous Assay Kit reactions PRMT6 (HRMT1L6), His-tag µg PRMT7, His-FLAG-tag µg PRMT8 Chemiluminescent Assay Kit reactions PRMT8, His-FLAG-tags µg PRMT9 Homogeneous Assay Kit reactions PRMT9, FLAG-Tag, His-Tag μg PRMT9, FLAG-Tag, Strep-Tag μg Recombinant Nucleosome (E. coli-derived) mg Recombinant Nucleosome (E. coli-derived) µg Recombinant Nucleosome (E. coli-derived), Biotin-labeled, Histag µg S-adenosyl homocysteine µl 15

16 METHYLTRANSFERASE(S) (CONT'D) S-adenosyl homocysteine, Fluorescein-labeled µl SAP145, GST-Tag μg Secondary Anti-HRP-labeled Antibody H 10 µl Set7/9 (Sf9), His-GST-tags µg Set7/Set9, GST-tag (E. coli-derived) µg Set8, Active, GST-tag µg SETD2, GST-tag µg SetDB1, His-GST-tags µg SGC mg SGC mg SMYD2 (KMT3C) Chemiluminescent Assay Kit reactions SMYD2 (KMT3C), FLAG-tag µg SMYD3 (35-end), GST-tag µg SMYD3 (full length), FLAG-tag µg SMYD3 Homogeneous Assay Kit reactions SMYD4 Chemiluminescent Assay Kit reactions SMYD4, FLAG-tag µg SUV39H1, Full Length, GST-tag µg SUV39H1, GST-tag µg SUV39H2, GST-tag µg SUV4-20H1, GST-tag µg SUV4-20H2, GST-tag µg SUZ12, His-FLAG-tags µg UNC mg UNC0321 (TFA salt) mg UNC mg WDR5, FLAG-tag μg WDR5, His-tag µg WDR5, His-Tag, Biotin-Labeled μg 16

17 6042 CORNERSTONE COURT WEST, STE. B SAN DIEGO, CA

18

Inhibition of DNA Methyltransferases Blocks Mutant Huntingtin-Induced Neurotoxicity

Inhibition of DNA Methyltransferases Blocks Mutant Huntingtin-Induced Neurotoxicity Supplementary Information Inhibition of DNA Methyltransferases Blocks Mutant Huntingtin-Induced Neurotoxicity Yanchun Pan 1, Takuji Daito 1, Yo Sasaki 2, Yong Hee Chung 1, Xiaoyun Xing 2, Santhi Pondugula

More information

Epigenetics and Cancer

Epigenetics and Cancer Epigenetics and Cancer Ya-Hui Chi March 24, 2016 1 Institute of Biotechnology and Pharmaceutical Research, NHRI, Zhunan, Taiwan Question 1: What causes cancer? Douglas Hanahan and Robert A. Weinberg 2

More information

Lecture 8. Eukaryotic gene regulation: post translational modifications of histones

Lecture 8. Eukaryotic gene regulation: post translational modifications of histones Lecture 8 Eukaryotic gene regulation: post translational modifications of histones Recap.. Eukaryotic RNA polymerases Core promoter elements General transcription factors Enhancers and upstream activation

More information

A Public Private Partnership facilitating Drug Discovery

A Public Private Partnership facilitating Drug Discovery A Public Private Partnership facilitating Drug Discovery SGC Toronto SGC Oxford Outline Challenges in Drug discovery: science and organisational/ process We do not know how to pick the right targets Epigenetic

More information

Tackling malignant melanoma epigenetically: histone lysine methylation

Tackling malignant melanoma epigenetically: histone lysine methylation Orouji and Utikal Clinical Epigenetics (2018) 10:145 https://doi.org/10.1186/s13148-018-0583-z REVIEW Tackling malignant melanoma epigenetically: histone lysine methylation Elias Orouji 1,2,3* and Jochen

More information

Supplementary Materials

Supplementary Materials Supplementary Materials Supplementary Materials and Methods Biochemical Methods Methods to assay HMT activities have been previously described (1). In vitro cell assays Proliferation and LCC calculations

More information

Quantitative profile of lysine methylation and acetylation of histones by LC-MS/MS

Quantitative profile of lysine methylation and acetylation of histones by LC-MS/MS Quantitative profile of lysine methylation and acetylation of histones by LC-MS/MS DISSERTATION zur Erlangung des akademischen Grades Doctor rerum naturalium (Dr. rer. nat.) vorgelegt der Fakultät Mathematik

More information

Epigenetic Heterogeneity of B-Cell Lymphoma: Chromatin Modifiers

Epigenetic Heterogeneity of B-Cell Lymphoma: Chromatin Modifiers Genes 2015, 6, 1076-1112; doi:10.3390/genes6041076 Article OPEN ACCESS genes ISSN 2073-4425 www.mdpi.com/journal/genes Epigenetic Heterogeneity of B-Cell Lymphoma: Chromatin Modifiers Lydia Hopp 1, *,

More information

Epigenetics in cancer stem cells

Epigenetics in cancer stem cells Toh et al. Molecular Cancer (2017) 16:29 DOI 10.1186/s12943-017-0596-9 REVIEW Epigenetics in cancer stem cells Tan Boon Toh 1, Jhin Jieh Lim 1 and Edward Kai-Hua Chow 1,2,3* Open Access Abstract Compelling

More information

Dissecting the role of H3K64me3 in mouse pericentromeric heterochromatin.

Dissecting the role of H3K64me3 in mouse pericentromeric heterochromatin. Supplementary Information Dissecting the role of H3K64me3 in mouse pericentromeric heterochromatin. Ulrike C. Lange 1, Stéphanie Siebert 2, Mark Wossidlo 3,4, Thomas Weiss 1, Céline Ziegler- Birling 2,

More information

Epigenetic Vulnerabilities in Triple-Negative Breast Cancer

Epigenetic Vulnerabilities in Triple-Negative Breast Cancer Epigenetic Vulnerabilities in Triple-Negative Breast Cancer By Ingrid Yunchi Kao A thesis submitted in conformity with the requirements for the degree of Master of Science Department of Medical Biophysics

More information

NEW DEVELOPMENTS IN EPIGENETICS AND POTENTIAL CLINICAL APPLICATIONS

NEW DEVELOPMENTS IN EPIGENETICS AND POTENTIAL CLINICAL APPLICATIONS NEW DEVELOPMENTS IN EPIGENETICS AND POTENTIAL CLINICAL APPLICATIONS Susan E. Bates, M.D. Columbia University Medical Center, New York, NY and J.J.P Bronx VA Medical Center, Bronx, NY TARGETING THE EPIGENOME

More information

Biochimica et Biophysica Acta

Biochimica et Biophysica Acta BBAGRM-00286; No. of pages: 19; 4C: 8, 12 Biochimica et Biophysica Acta xxx (2010) xxx xxx Contents lists available at ScienceDirect Biochimica et Biophysica Acta journal homepage: www.elsevier.com/locate/bbagrm

More information

Advances in histone methyltransferases and histone demethylases

Advances in histone methyltransferases and histone demethylases [Chinese Journal of Cancer 27:10, 296-301; October 2008]; 2008 Sun Yat-Sen University Cancer Center Review Advances in histone methyltransferases and histone demethylases Xi Wang and Wei-Guo Zhu Department

More information

Writing, erasing and reading histone lysine methylations

Writing, erasing and reading histone lysine methylations OPEN (2017) 49, e324; doi:10.1038/emm.2017.11 & 2017 KSBMB. All rights reserved 2092-6413/17 www.nature.com/emm REVIEW Writing, erasing and reading histone lysine methylations Kwangbeom Hyun, Jongcheol

More information

The Epigenome Tools 2: ChIP-Seq and Data Analysis

The Epigenome Tools 2: ChIP-Seq and Data Analysis The Epigenome Tools 2: ChIP-Seq and Data Analysis Chongzhi Zang zang@virginia.edu http://zanglab.com PHS5705: Public Health Genomics March 20, 2017 1 Outline Epigenome: basics review ChIP-seq overview

More information

The interplay of histone modifications writers that read

The interplay of histone modifications writers that read Review Histones and Chromatin Review series The interplay of histone modifications writers that read Tianyi Zhang, Sarah Cooper *, & Neil Brockdorff Abstract Histones are subject to a vast array of posttranslational

More information

Epigenetic modulators as therapeutic targets in prostate cancer

Epigenetic modulators as therapeutic targets in prostate cancer Graça et al. Clinical Epigenetics (2016) 8:98 DOI 10.1186/s13148-016-0264-8 REVIEW Epigenetic modulators as therapeutic targets in prostate cancer Open Access Inês Graça 1,2, Eva Pereira-Silva 1, Rui Henrique

More information

Epigenetics in ovarian cancer: premise, properties, and perspectives

Epigenetics in ovarian cancer: premise, properties, and perspectives Yang et al. Molecular Cancer (2018) 17:109 https://doi.org/10.1186/s12943-018-0855-4 REVIEW Epigenetics in ovarian cancer: premise, properties, and perspectives Open Access Qilian Yang 1, Yuqing Yang 2,

More information

EZH2 Inhibitors as Novel Cancer Therapeutics!!!! Robert A. Copeland, Ph.D.! Epizyme, Inc.!!! 20 November 2014!

EZH2 Inhibitors as Novel Cancer Therapeutics!!!! Robert A. Copeland, Ph.D.! Epizyme, Inc.!!! 20 November 2014! EZH2 Inhibitors as Novel Cancer Therapeutics Robert A. Copeland, Ph.D. Epizyme, Inc. 20 November 2014 2013 Accomplishments Disclosure Information EORTC-NCI-AACR Meeting, 20 November 2014 Robert A. Copeland,

More information

Global change in the epigenetic landscape is a hallmark of

Global change in the epigenetic landscape is a hallmark of Epigenetics in normal and malignant hematopoiesis: An overview and update 2017 Susumu Goyama and Toshio Kitamura Division of Cellular Therapy, The Institute of Medical Science, The University of Tokyo,

More information

Data Sheet. Fluorogenic HDAC 8 Assay Kit Catalog #: 50068

Data Sheet. Fluorogenic HDAC 8 Assay Kit Catalog #: 50068 Data Sheet Fluorogenic HDAC 8 Assay Kit Catalog #: 50068 DESCRIPTION: The Fluorogenic HDAC 8 Assay Kit is a complete assay system designed to measure histone deacetylase (HDAC) 8 activity for screening

More information

ISOXAZOLE INHIBITORS OF BROMODOMAINS

ISOXAZOLE INHIBITORS OF BROMODOMAINS ISOXAZOLE INHIBITORS OF BROMODOMAINS Paul Brennan SGC Oxford Nuffield Dept. of Clinical Medicine University of Oxford RSC Advances in Synthesis and Medicinal Chemistry 1 May 2012 INTRODUCING THE SGC A

More information

Yue Wei 1, Rui Chen 2, Carlos E. Bueso-Ramos 3, Hui Yang 1, and Guillermo Garcia-Manero 1

Yue Wei 1, Rui Chen 2, Carlos E. Bueso-Ramos 3, Hui Yang 1, and Guillermo Garcia-Manero 1 Genome-wide CHIP-Seq Analysis of Histone Methylation Reveals Modulators of NF- B Signaling And the Histone Demethylase JMJD3 Implicated in Myelodysplastic Syndrome Yue Wei 1, Rui Chen 2, Carlos E. Bueso-Ramos

More information

This article appeared in a journal published by Elsevier. The attached copy is furnished to the author for internal non-commercial research and

This article appeared in a journal published by Elsevier. The attached copy is furnished to the author for internal non-commercial research and This article appeared in a journal published by Elsevier. The attached copy is furnished to the author for internal non-commercial research and education use, including for instruction at the authors institution

More information

Structural Diversity of the Epigenetics Pocketome

Structural Diversity of the Epigenetics Pocketome Structural Diversity of the Epigenetics Pocketome Alexandre Cabaye 1,$, Kong T Nguyen 1,#, Lihua Liu 1, Vineet Pande 2, Matthieu Schapira 1,3,* 1 Structural Genomics Consortium, 101 College street, University

More information

Expert Intelligence for Better Decisions Epigenetics:

Expert Intelligence for Better Decisions Epigenetics: Expert Intelligence for Better Decisions Epigenetics: Emerging Targets, Available Technologies, Expert Interviews, and an Epigenetic Community Perspective Using This Document Insight Pharma Reports are

More information

Gene Expression DNA RNA. Protein. Metabolites, stress, environment

Gene Expression DNA RNA. Protein. Metabolites, stress, environment Gene Expression DNA RNA Protein Metabolites, stress, environment 1 EPIGENETICS The study of alterations in gene function that cannot be explained by changes in DNA sequence. Epigenetic gene regulatory

More information

The role of epigenetics in breast. cancer progression

The role of epigenetics in breast. cancer progression The role of epigenetics in breast cancer progression Aslı Dilber Yıldırım January 2013 Master thesis, Cancer Genomics & Developmental Biology Under daily supervision of Rick van Nuland, MSc Examiners:

More information

EPIGENETIC REGULATION OF HEMATOLOGICAL MALIGNANCIES

EPIGENETIC REGULATION OF HEMATOLOGICAL MALIGNANCIES EPIGENETIC REGULATION OF HEMATOLOGICAL MALIGNANCIES Elke De Bruyne, PhD Department of Hematology and Immunology-Myeloma Center Brussels, Vrije Universiteit Brussel No conflicts of intrest to disclose 14-2-2013

More information

NOVEL HISTONE DEMETHYLASE INHIBITORS SYNERGISTICALLY ENHANCE THE EFFECTS OF A DNA HYPOMETHYLATING AGENT IN BREAST CANCER CELLS. Benjamin R.

NOVEL HISTONE DEMETHYLASE INHIBITORS SYNERGISTICALLY ENHANCE THE EFFECTS OF A DNA HYPOMETHYLATING AGENT IN BREAST CANCER CELLS. Benjamin R. NOVEL HISTONE DEMETHYLASE INHIBITORS SYNERGISTICALLY ENHANCE THE EFFECTS OF A DNA HYPOMETHYLATING AGENT IN BREAST CANCER CELLS By Benjamin R. Leadem A dissertation submitted to The Johns Hopkins University

More information

Eukaryotic transcription (III)

Eukaryotic transcription (III) Eukaryotic transcription (III) 1. Chromosome and chromatin structure Chromatin, chromatid, and chromosome chromatin Genomes exist as chromatins before or after cell division (interphase) but as chromatids

More information

Epigenetics q&more 01.11

Epigenetics q&more 01.11 Laurie. Knight, istockphoto.com Epigenetics 6 Bookmarks About the reading of genes in the Book of Life Prof. Dr. Manfred Jung, Julia M. Wagner, Institute for Pharmaceutical Sciences, Albert-Ludwig-University

More information

TMEFF2 is an epigenetic modulator that promotes androgen independent growth in castrationresistant. prostate cancer cells. Joshua Corbin.

TMEFF2 is an epigenetic modulator that promotes androgen independent growth in castrationresistant. prostate cancer cells. Joshua Corbin. TMEFF2 is an epigenetic modulator that promotes androgen independent growth in castrationresistant prostate cancer cells by Joshua Corbin August, 2014 Director of Thesis: Maria Ruiz-Echevarria, Ph.D. Major

More information

Chromatin Regulation and the Histone Code in HIV Latency

Chromatin Regulation and the Histone Code in HIV Latency YALE JOURNAL OF BIOLOGY AND MEDICINE 90 (2017), pp.229-243. Review Chromatin Regulation and the Histone Code in HIV Latency Anne-Marie W. Turner a,b and David M. Margolis a,b,c,d,* a UNC HIV Cure Center,

More information

Altered Histone Modifications in Gliomas

Altered Histone Modifications in Gliomas REVIEW ARTICLE Brain Tumor Res Treat 2014;2(1):7-21 / pissn 2288-2405 / eissn 2288-2413 http://dx.doi.org/10.14791/btrt.2014.2.1.7 Altered Histone Modifications in Gliomas Young Zoon Kim Division of Neuro-Oncology,

More information

Therapeutic and Prognostic Role of Epigenetic Abnormalities in MDS. Stephen D. Nimer, MD Sylvester Comprehensive Cancer Center December 5, 2014

Therapeutic and Prognostic Role of Epigenetic Abnormalities in MDS. Stephen D. Nimer, MD Sylvester Comprehensive Cancer Center December 5, 2014 Therapeutic and Prognostic Role of Epigenetic Abnormalities in MDS Stephen D. Nimer, MD Sylvester Comprehensive Cancer Center December 5, 2014 DISCLOSURE I have no relevant financial relationships to disclose.

More information

Assay Report. Histone Deacetylase (HDAC) Inhibitor Assays Enzymatic Study of Compounds from Client

Assay Report. Histone Deacetylase (HDAC) Inhibitor Assays Enzymatic Study of Compounds from Client Assay Report Histone Deacetylase (HDAC) Inhibitor Assays Enzymatic Study of Compounds from Client Page 1 of 27 Client_HDAC _Year Month Day 1 Client_HDAC_Year Month Year HDAC Inhibitor Assays Study Sponsor:

More information

The Role of Protein Domains in Cell Signaling

The Role of Protein Domains in Cell Signaling The Role of Protein Domains in Cell Signaling Growth Factors RTK Ras Shc PLCPLC-γ P P P P P P GDP Ras GTP PTB CH P Sos Raf SH2 SH2 PI(3)K SH3 SH3 MEK Grb2 MAPK Phosphotyrosine binding domains: PTB and

More information

Molecular Cell Biology. Prof. D. Karunagaran. Department of Biotechnology. Indian Institute of Technology Madras

Molecular Cell Biology. Prof. D. Karunagaran. Department of Biotechnology. Indian Institute of Technology Madras Molecular Cell Biology Prof. D. Karunagaran Department of Biotechnology Indian Institute of Technology Madras Module-9 Molecular Basis of Cancer, Oncogenes and Tumor Suppressor Genes Lecture 6 Epigenetics

More information

Protein methylation CH 3

Protein methylation CH 3 Protein methylation CH 3 methionine S-adenosylmethionine (SAM or adomet) Methyl group of the methionine is activated by the + charge of the adjacent sulfur atom. SAM S-adenosylhomocysteine homocysteine

More information

Identification of a First-In-Class PRMT5 Inhibitor with Potent In Vitro and In Vivo Activity in Preclinical Models of Mantle Cell Lymphoma

Identification of a First-In-Class PRMT5 Inhibitor with Potent In Vitro and In Vivo Activity in Preclinical Models of Mantle Cell Lymphoma Identification of a First-In-Class PRMT5 Inhibitor with Potent In Vitro and In Vivo Activity in Preclinical Models of Mantle Cell Lymphoma Elayne Penebre, Kristy G Kuplast, Christina R Majer, P Ann Boriak-Sjodin,

More information

Epigenomics. Ivana de la Serna Block Health Science

Epigenomics. Ivana de la Serna Block Health Science Epigenomics Ivana de la Serna Block Health Science 388 383-4111 ivana.delaserna@utoledo.edu Outline 1. Epigenetics-definition and overview 2. DNA methylation/hydroxymethylation 3. Histone modifications

More information

HDAC1 Inhibitor Screening Assay Kit

HDAC1 Inhibitor Screening Assay Kit HDAC1 Inhibitor Screening Assay Kit Catalog Number KA1320 96 assays Version: 03 Intended for research use only www.abnova.com Table of Contents Introduction... 3 Background... 3 Principle of the Assay...

More information

Epigenome-based personalized medicine in human cancer

Epigenome-based personalized medicine in human cancer For reprint orders, please contact: reprints@futuremedicine.com Epigenome-based personalized medicine in human cancer Cancer genome sequencing has created an opportunity for precision medicine. Thus far,

More information

Mutations of Chromatin Structure Regulating Genes in Human Malignancies

Mutations of Chromatin Structure Regulating Genes in Human Malignancies Send Orders for Reprints to reprints@benthamscience.ae Current Protein and Peptide Science, 2016, 17, 411-437 411 Mutations of Chromatin Structure Regulating Genes in Human Malignancies Jian Chen*, Franklin

More information

Citi 10 th Annual Biotech Conference! September 9, 2015!!

Citi 10 th Annual Biotech Conference! September 9, 2015!! Citi 10 th Annual Biotech Conference! September 9, 2015!! Forward Looking Statements! Any statements in this presentation about future expectations, plans and prospects for Epizyme, Inc. and other statements

More information

Histones are post-translationally

Histones are post-translationally Perspective Cell Cycle 10:3, 413-424; February 1, 2011; 2011 Landes Bioscience Perspective Selective targeting of histone methylation Abul BMMK Islam, 1 William F. Richter, 2 Nuria Lopez-Bigas 1 and Elizaveta

More information

The Role of MIER1 and G9a in Histone 3 Lysine 27 (H3K27) Methylation. By Leena Derwish

The Role of MIER1 and G9a in Histone 3 Lysine 27 (H3K27) Methylation. By Leena Derwish The Role of MIER1 and G9a in Histone 3 Lysine 27 (H3K27) Methylation By Leena Derwish A thesis submitted to the School of Graduate Studies in partial fulfillment of the requirements for the degree of Masters

More information

This PDF file includes: Supplementary Figures 1 to 6 Supplementary Tables 1 to 2 Supplementary Methods Supplementary References

This PDF file includes: Supplementary Figures 1 to 6 Supplementary Tables 1 to 2 Supplementary Methods Supplementary References Structure of the catalytic core of p300 and implications for chromatin targeting and HAT regulation Manuela Delvecchio, Jonathan Gaucher, Carmen Aguilar-Gurrieri, Esther Ortega, Daniel Panne This PDF file

More information

Review Article Where Environment Meets Cognition: A Focus on Two Developmental Intellectual Disability Disorders

Review Article Where Environment Meets Cognition: A Focus on Two Developmental Intellectual Disability Disorders Neural Plasticity Volume 2016, Article ID 4235898, 20 pages http://dx.doi.org/10.1155/2016/4235898 Review Article Where Environment Meets Cognition: A Focus on Two Developmental Intellectual Disability

More information

Nature Genetics: doi: /ng Supplementary Figure 1. Depths and coverages in whole-exome and targeted deep sequencing data.

Nature Genetics: doi: /ng Supplementary Figure 1. Depths and coverages in whole-exome and targeted deep sequencing data. Supplementary Figure 1 Depths and coverages in whole-exome and targeted deep sequencing data. Depth (top) and coverage (bottom) of whole-exome sequencing for 38 independent JPN cases (mean depth = 130)

More information

Transcriptional and post-transcriptional regulation of telomerase reverse transcriptase (htert) expression. Zheng Ge 葛峥

Transcriptional and post-transcriptional regulation of telomerase reverse transcriptase (htert) expression. Zheng Ge 葛峥 Division of Hematology, Department of Medicine Karolinska Institutet, Stockholm, Sweden Transcriptional and post-transcriptional regulation of telomerase reverse transcriptase (htert) expression The role

More information

AGCGGCTGGTGTATGAGG AGCTCGAGCTGCAGGACT AAAGGTGCACTGGTAGCC AGGGCACAAGTGCATGGC CCCGCTGTGCAGAAGTAG

AGCGGCTGGTGTATGAGG AGCTCGAGCTGCAGGACT AAAGGTGCACTGGTAGCC AGGGCACAAGTGCATGGC CCCGCTGTGCAGAAGTAG Supplementary Table S1. Primer sequence information Gene Primer sequence 1 st round PCR 2 nd round PCR Accession# Dnmt3a TCAAGGAGATCATTGATG TGTTCCCACACATGAGCA AGCGGCTGGTGTATGAGG AGCAGATGGTGCAATAGGAC NM_007872.4

More information

Title Targeting p300 addiction in CBP-deficient cancers causes synthetic lethality by apoptotic cell death due to abrogation of MYC expression

Title Targeting p300 addiction in CBP-deficient cancers causes synthetic lethality by apoptotic cell death due to abrogation of MYC expression Supplementary Information Cancer Discovery Title Targeting p3 addiction in CBP-deficient cancers causes synthetic lethality by apoptotic cell death due to abrogation of MYC expression Authors Hideaki Ogiwara

More information

FOLLICULAR LYMPHOMA- ILLUMINA METHYLATION. Jude Fitzgibbon

FOLLICULAR LYMPHOMA- ILLUMINA METHYLATION. Jude Fitzgibbon FOLLICULAR LYMPHOMA- ILLUMINA METHYLATION Jude Fitzgibbon j.fitzgibbon@qmul.ac.uk Molecular Predictors of Clinical outcome Responders Alive Non-responders Dead TUMOUR GENETICS Targeted therapy, Prognostic

More information

Epigenetic Modulating Agents as a New Therapeutic Approach in Multiple Myeloma

Epigenetic Modulating Agents as a New Therapeutic Approach in Multiple Myeloma Cancers 2013, 5, 430-461; doi:10.3390/cancers5020430 Review OPEN ACCESS cancers ISSN 2072-6694 www.mdpi.com/journal/cancers Epigenetic Modulating Agents as a New Therapeutic Approach in Multiple Myeloma

More information

Lecture 10. Eukaryotic gene regulation: chromatin remodelling

Lecture 10. Eukaryotic gene regulation: chromatin remodelling Lecture 10 Eukaryotic gene regulation: chromatin remodelling Recap.. Eukaryotic RNA polymerases Core promoter elements General transcription factors Enhancers and upstream activation sequences Transcriptional

More information

Received September 3, 2013; Accepted October 12, 2013; Epub October 15, 2013; Published November 1, 2013

Received September 3, 2013; Accepted October 12, 2013; Epub October 15, 2013; Published November 1, 2013 Int J Clin Exp Pathol 2013;6(11):2357-2365 www.ijcep.com /ISSN:1936-2625/IJCEP1309013 Original Article SIRT1 is highly expressed in brain metastasis tissues of non-small cell lung cancer (NSCLC) and in

More information

STRUCTURAL AND BIOCHEMICAL INSIGHTS INTO METHYLATION SITE AND STATE SPECIFICITY OF JMJD2 LYSINE DEMETHYLASES. Swathi Krishnan

STRUCTURAL AND BIOCHEMICAL INSIGHTS INTO METHYLATION SITE AND STATE SPECIFICITY OF JMJD2 LYSINE DEMETHYLASES. Swathi Krishnan STRUCTURAL AND BIOCHEMICAL INSIGHTS INTO METHYLATION SITE AND STATE SPECIFICITY OF JMJD2 LYSINE DEMETHYLASES by Swathi Krishnan A dissertation submitted in partial fulfillment of the requirements for the

More information

Epigenetics in diabetic nephropathy, immunity and metabolism

Epigenetics in diabetic nephropathy, immunity and metabolism Diabetologia (2018) 61:6 20 https://doi.org/10.1007/s00125-017-4490-1 REVIEW Epigenetics in diabetic nephropathy, immunity and metabolism Samuel T. Keating 1 & Janna A. van Diepen 1 & Niels P. Riksen 1

More information

Androgen receptor epigenetics

Androgen receptor epigenetics Review Article Androgen receptor epigenetics Changmeng Cai, Xin Yuan, Steven P. Balk Hematology-Oncology Division, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School,

More information

Epigenetics DNA methylation. Biosciences 741: Genomics Fall, 2013 Week 13. DNA Methylation

Epigenetics DNA methylation. Biosciences 741: Genomics Fall, 2013 Week 13. DNA Methylation Epigenetics DNA methylation Biosciences 741: Genomics Fall, 2013 Week 13 DNA Methylation Most methylated cytosines are found in the dinucleotide sequence CG, denoted mcpg. The restriction enzyme HpaII

More information

AlphaScreen : A Straightforward and Powerful Alternative to ELISA. Martina Bielefeld-Sévigny Ph.D., R&D Director

AlphaScreen : A Straightforward and Powerful Alternative to ELISA. Martina Bielefeld-Sévigny Ph.D., R&D Director AlphaScreen : A Straightforward and Powerful Alternative to ELISA Martina Bielefeld-Sévigny Ph.D., R&D Director Overview AlphaScreen - an alternative to ELISA Why an alternative to ELISA? Assay principle

More information

Epigenetic Drivers in Pediatric Medulloblastoma

Epigenetic Drivers in Pediatric Medulloblastoma Cerebellum (2018) 17:28 36 https://doi.org/10.1007/s12311-017-0899-9 REVIEW Epigenetic Drivers in Pediatric Medulloblastoma Martine F. Roussel 1 & Jennifer L. Stripay 1 Published online: 25 November 2017

More information

Epigenetic regulation of HIV-1 latency: focus on polycomb group (PcG) proteins

Epigenetic regulation of HIV-1 latency: focus on polycomb group (PcG) proteins Khan et al. Clinical Epigenetics (2018) 10:14 DOI 10.1186/s13148-018-0441-z REVIEW Epigenetic regulation of HIV-1 latency: focus on polycomb group (PcG) proteins Sheraz Khan 1,2, Mazhar Iqbal 1,2, Muhammad

More information

Chromatin Structure & Gene activity part 2

Chromatin Structure & Gene activity part 2 Chromatin Structure & Gene activity part 2 Figure 13.30 Make sure that you understand it. It is good practice for identifying the purpose for various controls. Chromatin remodeling Acetylation helps to

More information

HDAC Cell-Based Activity Assay Kit

HDAC Cell-Based Activity Assay Kit HDAC Cell-Based Activity Assay Kit Item No. 600150 Customer Service 800.364.9897 * Technical Support 888.526.5351 www.caymanchem.com TABLE OF CONTENTS GENERAL INFORMATION 3 Materials Supplied 4 Precautions

More information

Epigenetics ~from mechanism to therapy~ Literature seminar January 31, 2012 Soichi Ito (B4)

Epigenetics ~from mechanism to therapy~ Literature seminar January 31, 2012 Soichi Ito (B4) Epigenetics ~from mechanism to therapy~ Literature seminar January 31, 2012 Soichi Ito (B4) 1 Contents Introduction Central dogma What is the Epigenetics? Topics 1. DNA methylation 2. Histone modification

More information

Beads-on-a- The 30nm Fibre Active Chromosome The Metaphase Chromosome. Less active genes During interphase During cell division

Beads-on-a- The 30nm Fibre Active Chromosome The Metaphase Chromosome. Less active genes During interphase During cell division Overview of Epigenetics Figure 2.2. The Increasing Structural Complexity of Genetic Information from the Double-Helical Structure of DNA, through Nucleosome and Chromatin Structures, to the Chromosome

More information

An Overview of the Molecular Basis of Epigenetics

An Overview of the Molecular Basis of Epigenetics C H A P T E R 1 An Overview of the Molecular Basis of Epigenetics J. David Sweatt, 1 Eric J. Nestler, 2 Michael J. Meaney 3 and Schahram Akbarian 4 1 McKnight Brain Institute, Department of Neurobiology,

More information

Supplementary Figure S1. Generation of LSL-EZH2 conditional transgenic mice.

Supplementary Figure S1. Generation of LSL-EZH2 conditional transgenic mice. Downstream Col1A locus S P P P EP Genotyping with P1, P2 frt PGKneopA + frt hygro-pa Targeting vector Genotyping with P3, P4 P1 pcag-flpe P2 P3 P4 frt SApA CAG LSL PGKATG frt hygro-pa C. D. E. ormal KRAS

More information

Cover design. my mother An Van de Vel

Cover design. my mother An Van de Vel Cover design my mother An Van de Vel II FACULTY OF MEDICINE AND HEALTH SCIENCES Ghent University, Faculty of Medicine and Health Sciences Lost in Transcription Emergence of Epigenetic Drivers and MicroRNAs

More information

ab Histone Deacetylase (HDAC) Activity Assay Kit (Fluorometric)

ab Histone Deacetylase (HDAC) Activity Assay Kit (Fluorometric) ab156064 Histone Deacetylase (HDAC) Activity Assay Kit (Fluorometric) Instructions for Use For the quantitative measurement of Histone Deacetylase activity in cell lysates This product is for research

More information

EPIGENTEK. EpiQuik Global Histone H4 Acetylation Assay Kit. Base Catalog # P-4009 PLEASE READ THIS ENTIRE USER GUIDE BEFORE USE

EPIGENTEK. EpiQuik Global Histone H4 Acetylation Assay Kit. Base Catalog # P-4009 PLEASE READ THIS ENTIRE USER GUIDE BEFORE USE EpiQuik Global Histone H4 Acetylation Assay Kit Base Catalog # PLEASE READ THIS ENTIRE USER GUIDE BEFORE USE The EpiQuik Global Histone H4 Acetylation Assay Kit is suitable for specifically measuring global

More information

The bromodomain interaction module

The bromodomain interaction module FEBS Letters 586 (2012) 2692 2704 journal homepage: www.febsletters.org Review The bromodomain interaction module Panagis Filippakopoulos a,, Stefan Knapp a,b, a Nuffield Department of Clinical Medicine,

More information

KDM2A. Reactions. containing. Reactions

KDM2A. Reactions. containing. Reactions Supplementary Figure 1 KDM2A catalyses only lysine demethylation.. MALDI-TOF MS of demethylation of the shown variant histone peptides as catalysed by recombinant KDM2A. Reactions containing enzyme are

More information

Access to DNA is regulated through post-transcriptional

Access to DNA is regulated through post-transcriptional pubs.acs.org/biochemistry Terms of Use Differences in Specificity and Selectivity Between CBP and p300 Acetylation of Histone H3 and H3/H4 Ryan A. Henry, Yin-Ming Kuo, and Andrew J. Andrews* Department

More information

Kidney Research and Clinical Practice

Kidney Research and Clinical Practice Kidney Res Clin Pract 31 (2012) 139 150 Kidney Research and Clinical Practice journal homepage: http://www.krcp-ksn.com Contents lists available at ScienceDirect Review article Epigenetic modifications

More information

Repression of IP-10 by Interactions between Histone Deacetylation and Hypermethylation in Idiopathic Pulmonary Fibrosis

Repression of IP-10 by Interactions between Histone Deacetylation and Hypermethylation in Idiopathic Pulmonary Fibrosis MOLECULAR AND CELLULAR BIOLOGY, June 2010, p. 2874 2886 Vol. 30, No. 12 0270-7306/10/$12.00 doi:10.1128/mcb.01527-09 Copyright 2010, American Society for Microbiology. All Rights Reserved. Repression of

More information

The role of histone demethylases in cancer therapy

The role of histone demethylases in cancer therapy MOLECULAR ONCOLOGY 6 (2012) 683e703 available at www.sciencedirect.com www.elsevier.com/locate/molonc Review The role of histone demethylases in cancer therapy Inga Hoffmann a, Martin Roatsch a, Martin

More information

RapidFire Selected Therapeutic Areas and Screening Techniques

RapidFire Selected Therapeutic Areas and Screening Techniques RapidFire Selected Therapeutic Areas and Screening Techniques RapidFire: SPE/MS/MS Life Sciences Group William A. LaMarr, Ph.D. Senior R&D Manager, RapidFire RapidFire Mass Spectrometry Ultra-fast autosampler

More information

HDAC Cell-Based Activity Assay Kit

HDAC Cell-Based Activity Assay Kit HDAC Cell-Based Activity Assay Kit Item No. 600150 www.caymanchem.com Customer Service 800.364.9897 Technical Support 888.526.5351 1180 E. Ellsworth Rd Ann Arbor, MI USA TABLE OF CONTENTS GENERAL INFORMATION

More information

One-carbon metabolism and epigenetics: understanding the specificity

One-carbon metabolism and epigenetics: understanding the specificity Ann. N.Y. Acad. Sci. ISSN 0077-8923 ANNALS OF THE NEW YORK ACADEMY OF SCIENCES Issue: Diet, Sulfur Amino Acids, and Health Span : understanding the specificity Samantha J. Mentch 1 and Jason W. Locasale

More information

PRC2 crystal clear. Matthieu Schapira

PRC2 crystal clear. Matthieu Schapira PRC2 crystal clear Matthieu Schapira Epigenetic mechanisms control the combination of genes that are switched on and off in any given cell. In turn, this combination, called the transcriptional program,

More information

DESIGN, SYNTHESIS AND BIOLOGICAL EVALUATION OF SMALL MOLECULES AS MODULATORS OF HISTONE METHYLTRANSFERASES AND DEMETHYLASES

DESIGN, SYNTHESIS AND BIOLOGICAL EVALUATION OF SMALL MOLECULES AS MODULATORS OF HISTONE METHYLTRANSFERASES AND DEMETHYLASES PhD School of Pharmaceutical Sciences XXVI cycle University of Naples Federico II DESIGN, SYNTHESIS AND BIOLOGICAL EVALUATION OF SMALL MOLECULES AS MODULATORS OF HISTONE METHYLTRANSFERASES AND DEMETHYLASES

More information

SUPPLEMENTARY INFORMATION

SUPPLEMENTARY INFORMATION doi:10.1038/nature10860 Supplementary Discussion It remains unclear why H3K9 demethylation appeared to be more sensitive to suppression than at least some other histone methylation marks as a result of

More information

Cancer Research Product Guide Edition 3 Euro

Cancer Research Product Guide Edition 3 Euro Cancer Research Product Guide Edition 3 Euro Contents by Research Area: Cancer Metabolism Epigenetics in Cancer Receptor Signaling Cell Cycle and DA Damage Repair Angiogenesis Invasion and Metastasis Autumn

More information

EPIGENTEK. EpiQuik Global Acetyl Histone H3K27 Quantification Kit (Colorimetric) Base Catalog # P-4059 PLEASE READ THIS ENTIRE USER GUIDE BEFORE USE

EPIGENTEK. EpiQuik Global Acetyl Histone H3K27 Quantification Kit (Colorimetric) Base Catalog # P-4059 PLEASE READ THIS ENTIRE USER GUIDE BEFORE USE EpiQuik Global Acetyl Histone H3K27 Quantification Kit (Colorimetric) Base Catalog # P-4059 PLEASE READ THIS ENTIRE USER GUIDE BEFORE USE The EpiQuik Global Acetyl Histone H3K27 Quantification Kit (Colorimetric)

More information

HDAC1 Inhibitor Screening Assay Kit

HDAC1 Inhibitor Screening Assay Kit HDAC1 Inhibitor Screening Assay Kit Item No. 10011564 www.caymanchem.com Customer Service 800.364.9897 Technical Support 888.526.5351 1180 E. Ellsworth Rd Ann Arbor, MI USA TABLE OF CONTENTS GENERAL INFORMATION

More information

EZH2: biology, disease, and structure-based drug discovery

EZH2: biology, disease, and structure-based drug discovery (2014) 35: 161 174 2014 CPS and SIMM All rights reserved 1671-4083/14 Review EZH2: biology, disease, and structure-based drug discovery Jin-zhi TAN 1, *, Yan YAN 1, Xiao-xi WANG 1, Yi JIANG 1, H Eric XU

More information

SPOTLIGHT. Chromatin modifiers and the promise of epigenetic therapy in acute leukemia SPOTLIGHT REVIEW OPEN. SM Greenblatt and SD Nimer

SPOTLIGHT. Chromatin modifiers and the promise of epigenetic therapy in acute leukemia SPOTLIGHT REVIEW OPEN. SM Greenblatt and SD Nimer Leukemia (2014) 28, 1396 1406 & 2014 Macmillan Publishers Limited All rights reserved 0887-6924/14 www.nature.com/leu OPEN REVIEW Chromatin modifiers and the promise of epigenetic therapy in acute leukemia

More information

R. Piazza (MD, PhD), Dept. of Medicine and Surgery, University of Milano-Bicocca EPIGENETICS

R. Piazza (MD, PhD), Dept. of Medicine and Surgery, University of Milano-Bicocca EPIGENETICS R. Piazza (MD, PhD), Dept. of Medicine and Surgery, University of Milano-Bicocca EPIGENETICS EPIGENETICS THE STUDY OF CHANGES IN GENE EXPRESSION THAT ARE POTENTIALLY HERITABLE AND THAT DO NOT ENTAIL A

More information

Development Of Elisa-Based Hdac Activity Assay For Identification Of Isoform Selective Hdac Inhibitors

Development Of Elisa-Based Hdac Activity Assay For Identification Of Isoform Selective Hdac Inhibitors Wayne State University Wayne State University Dissertations 1-1-2014 Development Of Elisa-Based Hdac Activity Assay For Identification Of Isoform Selective Hdac Inhibitors Geetha Padige Wayne State University,

More information

Title: Resetting the epigenome for heart regeneration. Author: Gregory A. Quaife-Ryan Choon Boon Sim Enzo R. Porrello James E.

Title: Resetting the epigenome for heart regeneration. Author: Gregory A. Quaife-Ryan Choon Boon Sim Enzo R. Porrello James E. Accepted Manuscript Title: Resetting the epigenome for heart regeneration. Author: Gregory A. Quaife-Ryan Choon Boon Sim Enzo R. Porrello James E. Hudson PII: S1084-9521(15)30035-5 DOI: http://dx.doi.org/doi:10.1016/j.semcdb.2015.12.021

More information

hset1 HISTONE METHYLTRANSFERASE ACTIVITY IS REQUIRED FOR TAL1- MEDIATED ACTIVATION OF TAL1 TARGET GENES DURING HEMATOPOIESIS

hset1 HISTONE METHYLTRANSFERASE ACTIVITY IS REQUIRED FOR TAL1- MEDIATED ACTIVATION OF TAL1 TARGET GENES DURING HEMATOPOIESIS hset1 HISTONE METHYLTRANSFERASE ACTIVITY IS REQUIRED FOR TAL1- MEDIATED ACTIVATION OF TAL1 TARGET GENES DURING HEMATOPOIESIS By RIVER SAENZ A THESIS PRESENTED TO THE GRADUATE SCHOOL OF THE UNIVERSITY OF

More information

Immune Checkpoint Proteins

Immune Checkpoint Proteins Immune Checkpoint Proteins www.acrobiosystems.com Content I. Introduction II. Biotinylated Immune Checkpoint Proteins III. PD1:PDL1 Inhibitor Screening Assay Kit IV. HPLC-Verified Checkpoint Proteins V.

More information

Epigenetic regulation in RCC: opportunities for therapeutic intervention?

Epigenetic regulation in RCC: opportunities for therapeutic intervention? Epigenetic regulation in RCC: opportunities for therapeutic intervention? James Larkin, Xin Yi Goh, Marcus Vetter, Lisa Pickering and Charles Swanton Abstract Renal cell carcinoma (RCC) is a constellation

More information

EpiQuik Total Histone H3 Acetylation Detection Fast Kit (Colorimetric)

EpiQuik Total Histone H3 Acetylation Detection Fast Kit (Colorimetric) EpiQuik Total Histone H3 Acetylation Detection Fast Kit (Colorimetric) Base Catalog # PLEASE READ THIS ENTIRE USER GUIDE BEFORE USE The EpiQuik Total Histone H3 Acetylation Detection Fast Kit (Colorimetric)

More information